H, P., E, M., KM, K., E, M., S, M., A, M., . . . MJ, B. (2021). Selective laser trabeculoplasty versus 0·5% timolol eye drops for the treatment of glaucoma in Tanzania: A randomised controlled trial. The Lancet. Global health, 9(11), e1589. https://doi.org/10.1016/S2214-109X(21)00348-X
Chicago Style (17th ed.) CitationH, Philippin, et al. "Selective Laser Trabeculoplasty Versus 0·5% Timolol Eye Drops for the Treatment of Glaucoma in Tanzania: A Randomised Controlled Trial." The Lancet. Global Health 9, no. 11 (2021): e1589. https://doi.org/10.1016/S2214-109X(21)00348-X.
MLA (9th ed.) CitationH, Philippin, et al. "Selective Laser Trabeculoplasty Versus 0·5% Timolol Eye Drops for the Treatment of Glaucoma in Tanzania: A Randomised Controlled Trial." The Lancet. Global Health, vol. 9, no. 11, 2021, p. e1589, https://doi.org/10.1016/S2214-109X(21)00348-X.